AXIUM DETACHABLE COIL SYSTEM REF QC-4-12-HELIX; Axium Detachable Coil System REF QC-10-30-3D;

FDA Device Recall #Z-1261-2022 — Class II — April 27, 2022

Recall Summary

Recall Number Z-1261-2022
Classification Class II — Moderate risk
Date Initiated April 27, 2022
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Micro Therapeutics, Inc.
Location Irvine, CA
Product Type Devices
Quantity 96 systems

Product Description

AXIUM DETACHABLE COIL SYSTEM REF QC-4-12-HELIX; Axium Detachable Coil System REF QC-10-30-3D;

Reason for Recall

Due to incorrect size and configuration labeling of the detachable coil system.

Distribution Pattern

International distribution in the countries of China and Republic of Korea.

Lot / Code Information

Product Number: QC-4-12-HELIX UDI-DI (GTIN) Code: 00847536029590 Lot Number: B240079 Product Number: QC-10-30-3D UDI-DI (GTIN) Code: 00847536030138 Lot Number: B240084

Other Recalls from Micro Therapeutics, Inc.

Recall # Classification Product Date
Z-1246-2025 Class I Medtronic Pipeline Vantage Embolization Device ... Jan 30, 2025
Z-1245-2025 Class I Medtronic Pipeline Vantage Embolization Device ... Jan 30, 2025
Z-1253-2024 Class II The Apollo Onyx Delivery Microcatheter (AOMC) i... Jan 11, 2024
Z-1252-2024 Class II The Apollo Onyx Delivery Microcatheter (AOMC) i... Jan 11, 2024
Z-1556-2022 Class II Echelon -14, 45 Tip Shape, REF 145-5092150, ste... Jun 30, 2022

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.